Sirnaomics Ltd. (HKG:2257)

Market Cap	762.88M +150.4%
Revenue (ttm)	7.45M +39.4%
Net Income	-110.02M
EPS	-1.27
Shares Out	106.40M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	87,050
Average Volume	202,503
Open	7.05
Previous Close	6.90
Day's Range	6.99 - 7.17
52-Week Range	2.50 - 22.78
Beta	-0.21
RSI	33.02
Earnings Date	Mar 27, 2026

About Sirnaomics

Sirnaomics Ltd., an RNA therapeutics biopharmaceutical company, discovers and develops drugs for indications with medical needs. The company’s therapeutics products focus on oncology and fibrosis, anticoagulant therapies, cardiometabolic disease, complement-mediated diseases, medical aesthetics, and viral infections. Its lead drug candidates include STP705 for the treatment of non-melanoma skin cancer and for focal fat reduction; and STP707 to treat solid tumors. The company is also developing STP122G for the treatment of coagulation disorders;...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2007
• Employees: 52
• Stock Exchange: Hong Kong Stock Exchange
• Ticker Symbol: 2257

Financial Performance

Financial numbers in USD